Bostal Drug Delivery and AustarPharma are pharmaceutical companies, founded by Dr. Ron Liu, specializing in drug delivery technologies. Bostal is located in Guangzhou China. It has about 500 employees and advanced laboratories, manufacturing sites and offices covering 68,000 m². AustarPharma is located in New Jersey, US. It has about 70 employees and an R&D and manufacturing facility previously owned by Abbott.
We are dedicated to build a "one-stop" platform for high quality CDMO services, and we have our own R&D pipelines for treatment of major diseases. Our services includes formulation development, pre-clinical studies, clinical studies, contract manufacturing, drug registration, and others.
We have established multiple high-end technology platforms for sterile and non-sterile drug product development. Our technology platforms includes oral sustained and controlled release preparations, solubilization of insoluble drugs, gastroretentive sustained-release preparations, orodispersible films, long-acting injectable microspheres, long-acting implants, injectable nanocrystal, injectable in-situ gel, liposome, etc. AustarPharma is also equipped to handle controlled-drugs from CII to C V and high potent/toxic drugs.
Bostal have R&D pipelines for treatment of major diseases including metabolic diseases, psychiatric disorders, malignant tumors, cardiovascular and cerebrovascular diseases. Some of drug products (diabetes ER tablets, NOAC capsules) are currently under investigation in pivotal clinical studies.
Both Bostal and Austarpharma have established an effective quality management system, which ascertains our manufacturing process to be in compliance with cGMP. Both of the companies has passed multiple inspections by the FDA, EMA, and NMPA.